Adverse Outcome Pathways [dráhy škodlivých účinků]

topical
2
Definition

Models connecting initiating events at the cellular and molecular level to population-wide impacts. Computational models may be at levels relating toxicology to adverse effects.

DUI
D000073931 MeSH Browser
CUI
M000625013
Previous indexing
Risk Assessment (2011-2017)
History note
2018
Public note
2018

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E05.318.740 Statistics as Topic 13 066
E05.318.740.600 Probability 275
E05.318.740.600.800 Risk 2 681
E05.318.740.600.800.715 Risk Assessment 6 016
E05.318.740.600.800.715.250 Adverse Outcome Pathways 2
E05.318.740.600.800.715.500 Healthcare Failure Mode and Effect Analysis 3
E05.599 Models, Theoretical 2 480
E05.599.395 Models, Biological 1 698
E05.599.395.040 Adverse Outcome Pathways 2
E05.599.395.080 Disease Models, Animal 3 210
E05.599.395.121 Epidemiological Models 13
E05.599.395.161 Models, Cardiovascular 202
E05.599.395.397 Models, Genetic 214
E05.599.395.500 Models, Immunological 39
E05.599.395.642 Models, Neurological 254
E05.599.395.821 Patient-Specific Modeling 17

N Health Care
N04.452.871 Risk Management 235
N04.452.871.715 Risk Assessment 6 016
N04.452.871.715.200 Adverse Outcome Pathways 2
N04.452.871.715.800 Risk Adjustment 301
N06.850 Public Health 4 036
N06.850.505.715 Risk Assessment 6 016
N06.850.505.715.250 Adverse Outcome Pathways 2
N06.850.505.715.750 Risk Evaluation and Mitigation 2